Skip to main content
Focused investors/Seth Klarman

Seth Klarman - Baupost Group

As of Q2 2026, Seth Klarman reported 23 long-equity positions worth $5.42B in aggregate.

Copy-investor backtest

Latest quarter
+3.22%
1-year
+20.94%
3-year
+48.31%
5-year
+12.01%
3-year vs S&P 500
-25.70%
5-year vs S&P 500
-61.90%
5-year top 5
-0.29%

Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.

Get email alerts when Seth Klarman files a new 13F — sign in or create a free account.

Updated 2026-06-06 from SEC 13F data.

Live quotes available for 3 of 18 rows. Rows without a quote are marked unavailable.

1VSATVIASAT INC COM22.65%-10,051,492$400.45M$39.84No quote
2NWSANEWS CORP CL A18.94%-19,050,000$334.9M$17.58No quote
3THRXTHERAVANCE INC COM17.81%-13,000,000$314.86MNo quoteNo quote
4ALRALERE INC COM6.86%-3,100,000$121.33MNo quoteNo quote
5ENZNENZON PHARMACEUTICALS INC COM5.55%Reduce -0.7%9,000,878$98.11MNo quoteNo quote
6ANVALLIED NEVADA GOLD CORP COM4.93%New2,456,398$87.15MNo quoteNo quote
7CSECAPITALSOURCE INC COM4.16%Reduce -34.7%10,450,000$73.57MNo quoteNo quote
8BBEPQBREITBURN ENERGY PARTNERS LP COM UT LTD PTN3.71%Reduce -30.6%3,021,000$65.65MNo quoteNo quote
9PDLIPDL BIOPHARMA INC COM3.44%Add +87.3%10,495,225$60.87MNo quoteNo quote
10-THERAVANCE INC NOTE 3.000% 1/1CUSIP 88338TAA23.29%-51,000,000$58.08MNo quoteNo quote
11AVEOAVEO PHARMACEUTICALS INC COM2.66%Add +76.3%3,525,000$46.95MNo quoteNo quote
12AOIALLIANCE ONE INTL INC COM2.00%-8,786,700$35.32MNo quoteNo quote
13ITRNITURAN LOCATION AND CONTROL SHS1.43%Reduce -2.1%1,685,666$25.29M$15.00No quote
14ELOSSYNERON MEDICAL LTD ORD SHS1.11%-1,500,000$19.56MNo quoteNo quote
15MGAMMULTIMEDIA GAMES INC COM0.84%-2,600,000$14.9MNo quoteNo quote
16VOXXAUDIOVOX CORP CL A0.48%-1,060,576$8.49MNo quoteNo quote
17SCMRSYCAMORE NETWORKS INC COM NEW0.14%New100,000$2.44MNo quoteNo quote
18REGNREGENERON PHARMACEUTICALS COM-Sold0$0No quoteNo quote